81 – 90 of 182
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
- Contribution to journal › Article
-
Mark
Mitochondrial DNA polymorphisms are associated with susceptibility and phenotype of systemic lupus erythematosus.
- Contribution to journal › Article
- 2008
-
Mark
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study
- Contribution to journal › Article
-
Mark
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis
- Contribution to journal › Article
-
Mark
Role of C1q in regulation of IFN-alpha production
(2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.706-706
- Contribution to journal › Published meeting abstract
-
Mark
SLE serum induces classical caspase-dependent apoptosis independent of death receptors
- Contribution to journal › Article
-
Mark
The incidence of renal vasculitis in southern Sweden
(2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.848-848
- Contribution to journal › Published meeting abstract
-
Mark
EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics
- Contribution to journal › Scientific review
-
Mark
Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus
- Contribution to journal › Article
-
Mark
Improved Lupus Outcome. We Are Doing a Good Job, But Could We Do Better?
- Contribution to journal › Debate/Note/Editorial
